DrugPatentWatch Database Preview

Taro Company Profile

« Back to Dashboard

What is the competitive landscape for TARO, and what generic alternatives to TARO drugs are available?

TARO has two hundred and twenty-one approved drugs.

There are six US patents protecting TARO drugs. There are three tentative approvals on TARO drugs.

There are forty-one patent family members on TARO drugs in sixteen countries and one hundred and two supplementary protection certificates in twelve countries.

Summary for Taro

International Patents:	41
US Patents:	6
Tradenames:	115
Ingredients:	98
NDAs:	221
Patent Litigation for Taro:	See patent lawsuits for Taro
PTAB Cases with Taro as petitioner:	See PTAB cases with Taro as petitioner

Drugs and US Patents for Taro

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Taro Pharm	DAPSONE	dapsone	TABLET;ORAL	209430-001	Mar 1, 2019	AB	RX	No	No
Taro Pharm Inds	LAMOTRIGINE	lamotrigine	TABLET;ORAL	078525-003	Jan 27, 2009	AB	RX	No	No
Taro Pharms	NAFTIFINE HYDROCHLORIDE	naftifine hydrochloride	CREAM;TOPICAL	205975-001	Sep 8, 2016		RX	No	Yes
Taro	MICONAZOLE 3	miconazole nitrate	CREAM;VAGINAL	076773-001	Mar 2, 2005		OTC	No	No
Taro	ORALONE	triamcinolone acetonide	PASTE;DENTAL	071383-001	Jul 6, 1987		DISCN	No	No
Taro	CARBAMAZEPINE	carbamazepine	TABLET, EXTENDED RELEASE;ORAL	078115-001	Mar 31, 2009	AB	RX	No	No

Expired US Patents for Taro

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Taro	FLO-PRED	prednisolone acetate	SUSPENSION;ORAL	022067-001	Jan 17, 2008	6,102,254
Taro	FLO-PRED	prednisolone acetate	SUSPENSION;ORAL	022067-002	Jan 17, 2008	6,656,482
Taro	FLO-PRED	prednisolone acetate	SUSPENSION;ORAL	022067-001	Jan 17, 2008	6,399,079
Taro	FLO-PRED	prednisolone acetate	SUSPENSION;ORAL	022067-001	Jan 17, 2008	5,881,926
Taro	FLO-PRED	prednisolone acetate	SUSPENSION;ORAL	022067-002	Jan 17, 2008	5,881,926
Taro	FLO-PRED	prednisolone acetate	SUSPENSION;ORAL	022067-001	Jan 17, 2008	6,656,482

Paragraph IV (Patent) Challenges for TARO drugs

Drugname	Dosage	Strength	Tradename	Submissiondate
	Topical Lotion	0.5%		2011-03-16
	Topical Spray	0.25%		2013-12-18

International Patents for Taro Drugs

Country	Patent Number	Estimated Expiration
Japan	2009500422
China	1376043
European Patent Office	2630951
South Africa	200800926
European Patent Office	1702597
Portugal	1244401

Supplementary Protection Certificates for Taro Drugs

Patent Number	Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
1304992	92401	Luxembourg		PRODUCT NAME: CLINDAMYCINE(EN TANT QUE PHOPSHATE DE CLINDAMYCINE)ET TRETINOINE
2203431	2015/009	Ireland		PRODUCT NAME: DASABUVIR OR A SALT THEREOF, INCLUDING DASABUVIR SODIUM MONOHYDRATE; REGISTRATION NO/DATE: EU/1/14/983 20150115
1519731	92269	Luxembourg		PRODUCT NAME: AZELASTINE,OU UN SEL PHARMACEUTIQUEMENT ACCEPTABLE DE CELUICI,ET UN ESTER PHARMACEUTIQUEMENT ACCEPTABLE DE FLUTICASONE
1110543	SPC/GB08/005	United Kingdom		SUPPLEMENTARY PROTECTION CERTIFICATE NO SPC/GB08/005 GRANTED TO MERCK SHARP + DOHME CORP. IN RESPECT OF THE PRODUCT DESLORATADINE OPTIONALLY IN THE FORM OF A PHARMACEUTICALLY ACCEPTABLE SALT, IN COMBINATION WITH PSEUDOEPHEDRINE OPTIONALLY IN THE FORM OF A PHARMACEUTICALLY ACCEPTABLE SALT OR ESTER, THE GRANT OF WHICH WAS ADVERTISED IN JOURNAL NO 6322 DATED 21 JULY 2010 HAS HAD ITS MAXIMUM PERIOD OF DURATION CORRECTED, SUBJECT TO THE PAYMENT OF THE PRESCRIBED FEES IT WILL EXPIRE ON 31 JULY 2022.
0266730	SPC/GB97/005	United Kingdom		PRODUCT NAME: DOLASETRON, OR A PHARMACEUTICALLY-ACCEPTABLE ACID ADDITION OR QUATERNARY AMMONIUM SALT THEREOF; REGISTERED: UK 04425/0150 19960926
0145340	SPC/GB99/003	United Kingdom		PRODUCT NAME: IMIQUIMOD; REGISTERED: UK EU/1/98/080/001 19980918

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

• Taro
• Taro Pharm
• Taro Pharm Inds
• Taro Pharm Inds Ltd
• Taro Pharms
• Taro Pharms Ireland